Ine Moors

Conference Paper

Systemic mastocytosis with myeloid sarcoma and B-CLL: molecular and clonal heterogeneity in a rare case of SM-AHN

Philippe Decruyenaere (UGent) , Dominiek Mazure (UGent) , Ine Moors (UGent) , Jo Van Dorpe (UGent) , Malaïka Van der Linden (UGent) , Barbara Denys (UGent) , Mattias Hofmans (UGent) and Fritz Offner (UGent)

(2023)

Add to list

Added value of baseline chest CT scan for IPA diagnosis in AML patients receiving intensive chemotherapy : a retrospective single-centre cohort study

Sammy Huygens (UGent) , Emilie Janssens, Ine Moors (UGent) , Tessa Kerre (UGent) , Anke Delie (UGent) , Lieve Morbée (UGent) and Alexander Schauwvlieghe (UGent)

(2023) 38th General Annual Meeting of the Belgian Hematology Society 2023, Abstracts.

Add to list

Systemic mastocytosis with myeloid sarcoma and B-CLL : molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature

Philippe Decruyenaere (UGent) , Dominiek Mazure (UGent) , Ine Moors (UGent) , Jo Van Dorpe (UGent) , Malaïka Van der Linden (UGent) , Barbara Denys (UGent) , Mattias Hofmans (UGent) and Fritz Offner (UGent)

(2023) ACTA CLINICA BELGICA. 78(1). p.58-66

Add to list

Value of baseline CT scan for early diagnosis of IPA in AML patients

Emilie Janssens, Sammy Huygens, Ine Moors (UGent) , Tessa Kerre (UGent) , Anke Delie (UGent) , Lieve Morbée (UGent) and Alexander Schauwvlieghe (UGent)

(2022) BONE MARROW TRANSPLANTATION. In Bone Marrow Transplantation 57(Supplement 1).

Add to list

Identification of the most important factors related to people with cancer starting a palliative care conversation : a survey study

Anne-Lore Scherrens (UGent) , Kim Beernaert (UGent) , Luc Deliens (UGent) , Lore Lapeire (UGent) , Martine De Laat (UGent) , Christine Biebuyck (UGent) , Karen Geboes (UGent) , Charles Van Praet (UGent) , Ine Moors (UGent) , Benedicte Deforche (UGent) , et al.

(2022) PSYCHO-ONCOLOGY. 31(11). p.1843-1851

Add to list

The value of baseline chest CT scan for the diagnosis of ipa in patients with AML treated with intensive chemotherapy : a retrospective single-centre cohort study

Els Janssens (UGent) , Sammy Huygens, Ine Moors (UGent) , Tessa Kerre (UGent) , Anke Delie (UGent) , Lieve Morbée (UGent) , Jerina Boelens (UGent) and Alexander Schauwvlieghe (UGent)

(2022) BONE MARROW TRANSPLANTATION. In Bone Marrow Transplantation 57(Supplement 1). p.266-267

Add to list

A mini-review on aplastic anemia, illustrated by a case report on bone marrow hot pockets mimicking sclerotic bone metastases

Emilie Janssens, Jo Van Dorpe (UGent) , VANESSA VAN HENDE (UGent) , Ine Moors (UGent) , Philip Vlummens (UGent) and Ciel De Vriendt (UGent)

(2022) ACTA CLINICA BELGICA. 77(2). p.410-415

Add to list

Journal Article
A1
open access

Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study) : a retrospective comparative cohort study

Alexander Schauwvlieghe (UGent) , A. Dunbar, E. Storme, A. Vlak, R. Aerts, J. Maertens, B. Sciot, T. Van der Wel, G. Papageorgiou, Ine Moors (UGent) , et al.

(2021) ECLINICALMEDICINE. 35.

Add to list

Journal Article
A1
open access

Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with AML and high risk MDS

Jeroen Janssen, Bob Lowenberg, Markus Manz, Mario Bargetzi, Bart Biemond, Peter von Dem Borne, Dimitri Breems, Rolf Brouwer, Yves Chalandon, Dries Deeren, et al.

(2021) CANCERS. 13(4).

Add to list

Journal Article
A1
open access

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial

Bob Lowenberg, Thomas Pabst, Johan Maertens, Patrycja Gradowska, Bart J. Biemond, Olivier Spertini, Edo Vellenga, Laimonas Griskevicius, Lidwine W. Tick, Mojca Jongen-Lavrencic, et al.

(2021) BLOOD ADVANCES. 5(4). p.1110-1121

Academic Bibliography

Ine Moors

Systemic mastocytosis with myeloid sarcoma and B-CLL: molecular and clonal heterogeneity in a rare case of SM-AHN

Added value of baseline chest CT scan for IPA diagnosis in AML patients receiving intensive chemotherapy : a retrospective single-centre cohort study

Systemic mastocytosis with myeloid sarcoma and B-CLL : molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature

Value of baseline CT scan for early diagnosis of IPA in AML patients

Identification of the most important factors related to people with cancer starting a palliative care conversation : a survey study

The value of baseline chest CT scan for the diagnosis of ipa in patients with AML treated with intensive chemotherapy : a retrospective single-centre cohort study

A mini-review on aplastic anemia, illustrated by a case report on bone marrow hot pockets mimicking sclerotic bone metastases

Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study) : a retrospective comparative cohort study

Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with AML and high risk MDS

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial

Contents

Support

Contact